Cargando…
Mitomycin induced pulmonary veno-occlusive disease
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxicity as well as PVOD adverse effec...
Autores principales: | Kunadu, Afua, Stalls, J. Stephen, Labuschagne, Heloise, Thayyil, Abdullah, Falls, Randall, Maddipati, Veeranna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348923/ https://www.ncbi.nlm.nih.gov/pubmed/34401312 http://dx.doi.org/10.1016/j.rmcr.2021.101437 |
Ejemplares similares
-
Genetic cause of pulmonary veno-occlusive disease
por: Mohite, Kaustubh, et al.
Publicado: (2022) -
Differential Expression Profile of microRNAs and Tight Junction in the Lung Tissues of Rat With Mitomycin-C-Induced Pulmonary Veno-Occlusive Disease
por: Song, Qing, et al.
Publicado: (2022) -
Progression of pulmonary veno‐occlusive disease without pulmonary hypertension
por: Beshay, Sarah, et al.
Publicado: (2022) -
Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease
por: Turco, Célia, et al.
Publicado: (2015) -
Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension
por: Hajouli, Said, et al.
Publicado: (2019)